Article

Latest Updates in Cancer Research Announced at European Oncology Congress

Several studies announcing the latest research in different cancers, including prostate, breast and lung cancers, were presented at the 2014 European Society of Medical Oncology's annual meeting in Madrid, Spain.

Several studies announcing the latest research in different cancers, including prostate, breast and lung, were presented at the 2014 European Society of Medical Oncology's annual meeting in Madrid, Spain. Laura Jones and Tara Petersen, of OncLive, discuss studies from this year's annual ESMO Congress.

Related Videos
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Related Content
FDA sign.
April 1st 2025

Dive Into March 2025 FDA Approvals Across Cancer Subtypes

Ryan Scott
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
"FDA" text.
March 28th 2025

FDA Expands Pluvicto Indication in Prostate Cancer Subset

Spencer Feldman
FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with androgen receptor inhibitors.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population: © Konstantin Yuganov - stock.adobe.com
March 28th 2025

Childhood Cancer Survivors May Experience Sooner Aging-Related Disease

Alex Biese
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
Image of doctor and man.
March 23rd 2025

Reducing Bowel Complications Following Radiation in Prostate Cancer

Ryan Scott
SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation therapy in prostate cancer.